- Supported exchanges /
- AU /
- NYR.AU
Nyrada Inc (NYR AU) stock market data APIs
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases. Its develops oral Proprotein Convertase Subtilisin/Kexin Type 9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; and neuroprotectant drug to reduce long-term disability in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.
Nyrada Inc Financial Data Overview
0.057 | |
0.057 | |
- | |
0.057 | |
0.057 | |
0.018-0.165 | |
10 386 K | |
182 M | |
3 242 K | |
1.424 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Nyrada Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 242 K
- EBITDA -1 547 140
- Earnings Per Share -0.01
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Nyrada Inc Earnings via APIs
- Latest Release 2024-08-22
- EPS/Forecast NaN
Get Nyrada Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: